Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Pontes HA et al. | Oral candidiasis mimicking an oral squamous cell carcinoma: report of a case. | 2012 | Gerodontology | pmid:20633054 |
| da Silva WJ et al. | Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents. | 2012 | Braz Dent J | pmid:23338267 |
| Ocerin-Guerra I et al. | Nystatin-induced acute generalized exanthematous pustulosis. | 2012 | Actas Dermosifiliogr | pmid:23149047 |
| Castón JJ et al. | [Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp]. | 2012 | Med Clin (Barc) | pmid:23103103 |
| Matsubara VH et al. | Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2). | 2012 | Oral Dis | pmid:22059932 |
| Seipke RF et al. | Isolating antifungals from fungus-growing ant symbionts using a genome-guided chemistry approach. | 2012 | Meth. Enzymol. | pmid:23084933 |
| Kaczorowska-Hac B et al. | Methemoglobinemia in postchemotherapy stomatitis topical treatment: 2 pediatric cases. | 2012 | J. Pediatr. Hematol. Oncol. | pmid:21900833 |
| Agwu E et al. | Distribution of yeast species associated with oral lesions in HIV-infected patients in Southwest Uganda. | 2012 | Med. Mycol. | pmid:21905950 |
| Houlton JJ et al. | Intranasal drug-induced fungal rhinopharyngitis. | 2012 Mar-Apr | Int Forum Allergy Rhinol | pmid:22253034 |
| Heneedak HM et al. | HPLC and chemometric methods for the simultaneous determination of miconazole nitrate and nystatin. | 2012 Nov-Dec | J Chromatogr Sci | pmid:22879356 |
| Alcântara CS et al. | Peel bond strength of resilient liner modified by the addition of antimicrobial agents to denture base acrylic resin. | 2012 Nov-Dec | J Appl Oral Sci | pmid:23329241 |
| Perez R et al. | The effect of topically applied antimycotic agents on inner ear vestibular and cochlear function. | 2013 | Laryngoscope | pmid:22991276 |
| Godoy JS et al. | Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis. | 2013 | J. Oral Pathol. Med. | pmid:22978344 |
| Silva S et al. | The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic. | 2013 | Med. Mycol. | pmid:22803822 |
| Kim DH et al. | Differential regulation of CC chemokine ligand 2 and CXCL8 by antifungal agent nystatin in macrophages. | 2013 | Biochem. Biophys. Res. Commun. | pmid:23831464 |
| Demirel G et al. | Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants. | 2013 | Eur. J. Pediatr. | pmid:23703468 |
| Monteiro DR et al. | Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. | 2013 | Mycoses | pmid:23773119 |
| El-Wahidi M et al. | [Bio-guided isolation of an antifungal from Haliclona enamela collected from Jorf Lasfar port, Morocco]. | 2013 | J Mycol Med | pmid:23726234 |
| Gerstein AC | Mutational effects depend on ploidy level: all else is not equal. | 2013 | Biol. Lett. | pmid:23054913 |
| MarÃn-Quintero D et al. | Formulation design and optimization for the improvement of nystatin-loaded lipid intravenous emulsion. | 2013 | J Pharm Sci | pmid:23970386 |